Home 2019 May

Monthly Archives: May 2019

A public meeting on cannabidiol (CBD) products will be held Friday by the U.S. Food and Drug Administration

FDA to Hold First Public Meeting on CBD

Scheduled speakers will include doctors, consumers, and cannabis industry members
Older adults with impaired vision are at increased risk for perceived discrimination

Impaired Vision Tied to Perceived Discrimination in Older Adults

Further, perceived discrimination associated with poorer emotional well-being
Fasting before a cholesterol test is not necessary when evaluating risk for cardiovascular events

Nonfasting Lipid Levels Adequate for Assessing Cardiovascular Risk

Fasting, nonfasting levels show similar associations with cardiovascular events even for patients on statins
The U.S. pathologist workforce decreased in both absolute and population-adjusted numbers from 2007 to 2017

2007 to 2017 Saw Decline in Number of U.S. Pathologists

At the same time, the cancer-related diagnostic workload rose 42 percent per pathologist
Positive cultural beliefs around taking aspirin for prevention of cardiovascular disease are associated with greater adoption of the intervention among African-Americans

Providers, Peers Influence Aspirin Use Among African-Americans

Positive social environment around a prevention approach may increase uptake, authors say
Five months into 2019

CDC: Reported Measles Cases Reach 971

With continued outbreaks, CDC says U.S. risks losing measles elimination status
Taking proton pump inhibitors is associated with an excess of cause-specific mortality

Excess Cause-Specific Mortality Tied to Chronic Proton Pump Inhibitor Use

Excess mortality due to CVD, CKD, upper GI cancer for those with no indication for PPI use
The International Pediatric Multiple Sclerosis Study Group has updated standards for future clinical trials in pediatric multiple sclerosis; the new recommendations were published in the May 28 issue of Neurology.

Recommendations Developed for Pediatric Multiple Sclerosis Trials

Biological rationale exists for using treatments proven efficacious in adults with MS for pediatric MS
The rate of emergency department visits with opioids only given during the visit is higher than the rate for visits with opioids only prescribed at discharge and for visits with opioids given and prescribed

More Opioids Given Than Prescribed in Emergency Department

Opioids more often given in ED than prescribed at discharge for adult ED visits
Clinical manifestations of systemic lupus erythematosus vary by racial and ethnic groups

Lupus Manifestations Appear to Differ by Race, Ethnicity

Increased risk for severe manifestations seen among blacks, Hispanics, and Asians/Pacific Islanders